A Study of Doxorubicin Hydrochloride Liposome Injection in Subjects With Ovarian Cancer.
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Rakesh J Patel, MD Pharm
Lambda Therapeutic Research Ltd.
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
15 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Mnj Institute of Oncology & Regional Cancer Center
Hyderabad, Andhra Pradesh, India
- Hcg City Cancer Centre
Vijayawada, Andhra Pradesh, India
- Mahatma Gandhi Cancer Hospital & Research Institute
Visakhapatnam, Andhra Pradesh, India
- Nirmal Hospital Pvt. Ltd.
Surat, Gujarat, India
- Unique Hospital - Multispeciality and Research Institute
Surat, Gujarat, India
- Aman Hospital and Research Center
Vadodara, Gujarat, India
- Kailash Cancer Hospital and Research Center
Vadodara, Gujarat, India
- K R Hospital
Mysore, Karnataka, India
- Apex Wellness Rishikesh Hospital
Nashik, Maharashtra, India
- Hcg Manavata Cancer Centre
Nashik, Maharashtra, India
- Noble Hospital Pvt Ltd.
Pune, Maharashtra, India
- Sparsh Hospitals & Critical Care (p) Ltd.
Bhubaneswar, Odisha, India
- Saveetha Medical College & Hospital
Chennai, Tamil Nadu, India
- Sri Ramachandra Medical Centre
Chennai, Tamil Nadu, India
- Vgm Hospital
Coimbatore, Tamil Nadu, India
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 29 Aug 2018
- Primary completion
- 8 Feb 2019
- Completion
- 7 Mar 2019
- Last update posted
- 20 Nov 2019
- Registered enrollment
- 52
- Registry id
- NCT03681548
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.